Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients

AG Nair, NG Adulkar, L D'Cunha, PR Rao, RA Bradoo… - Orbit, 2021 - Taylor & Francis
Purpose To report a series of 13 immunocompetent patients who developed new-onset
uncontrolled diabetes mellitus (DM) following COVID-19 infection and presented as rhino …

Epidemiology, clinical features and management of rhino orbital mucormycosis in post COVID 19 patients

EJ Desai, A Pandya, I Upadhya, T Patel… - Indian Journal of …, 2022 - Springer
COVID 19 infections may be associated with a wide range of bacterial and fungal co-
infections. Mucormycosis is a fungal infection primarily affecting immunocompromised …

Rhino-orbital mucormycosis during steroid therapy in COVID-19 patients: A case report

A Veisi, A Bagheri, M Eshaghi… - European journal of …, 2022 - journals.sagepub.com
Purpose: To report two cases of COVID-19 under treatment with a corticosteroid; in one case
rhino-orbitocerebral mucormycosis and in another one rhino-orbital mucormycosis …

COVID‐19 and Mucormycosis Coinfection: How Challenging It Is

N Nayak, E Khan, D Panigrahi - Canadian Journal of Infectious …, 2022 - Wiley Online Library
Recently, cases of rhinoorbital mucormycosis in people diagnosed with COVID‐19 have
been reported from India particularly. Diabetes mellitus though happens to be an …

Increased incidence of rhino‐orbital mucormycosis in an educational therapeutic hospital during the COVID‐19 pandemic in western Iran: an observational study

M Avatef Fazeli, L Rezaei, E Javadirad, K Iranfar… - Mycoses, 2021 - Wiley Online Library
Background COVID‐19 patients, especially the patients requiring hospitalisation, have a
high risk of several complications such as opportunistic bacterial and fungal infections …

Management outcomes of mucormycosis in COVID-19 patients: A preliminary report from a tertiary care hospital

A Kumari, NP Rao, U Patnaik, V Malik… - medical journal armed …, 2021 - Elsevier
Abstract Background Coronavirus disease 2019 (COVID-19) continues to be a significant
health problem worldwide. The unprecedented surge of mucormycosis in patients with …

Mucormycosis in patients with COVID‐19: a cross‐sectional descriptive multicentre study from Iran

F Pakdel, K Ahmadikia, M Salehi, A Tabari, R Jafari… - Mycoses, 2021 - Wiley Online Library
Purpose The aim of the study was to report clinical features, contributing factors and
outcome of patients with coronavirus disease 2019 (COVID‐19)‐associated mucormycosis …

COVID-19 associated rhino–orbital–cerebral mucormycosis—an institutional series

S Naruka, N Rana, N Singh… - Ear, Nose & Throat …, 2022 - journals.sagepub.com
Mucormycosis is almost always confined to the patients with altered host defenses amongst
which diabetes is considered as the strongest risk factor. COVID-19 only been seen in …

COVID-19 associated mucormycosis: the urgent need to reconsider the indiscriminate use of immunosuppressive drugs

AJ Rodriguez-Morales, R Sah… - Therapeutic …, 2021 - journals.sagepub.com
Therapeutic Advances in Infectious Disease 8 2 journals. sagepub. com/home/tai caring for
patients with COVID-19, the empiric overuse of corticosteroids has been associated with …

Post Covid-19 infection presenting as rhino-orbital mycosis

R Garg, S Bharangar, S Gupta, S Bhardwaj - Indian Journal of …, 2022 - Springer
Rhino-orbital mycosis has been recently recognised as one of the sequelae in COVID-19
recovered patients. In India, detection of mucormycosis is declared as notifiable disease. In …